Bio-Rad Laboratories Current Ratio 2006-2021 | BIO.B

Current and historical current ratio for Bio-Rad Laboratories (BIO.B) from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bio-Rad Laboratories current ratio for the three months ending June 30, 2021 was 3.90.
Bio-Rad Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $2.29B $0.59B 3.90
2021-03-31 $2.18B $0.61B 3.57
2020-12-31 $2.14B $0.63B 3.39
2020-09-30 $2.32B $0.99B 2.36
2020-06-30 $2.13B $0.93B 2.30
2020-03-31 $2.08B $0.87B 2.40
2019-12-31 $2.18B $0.91B 2.41
2019-09-30 $2.05B $0.43B 4.72
2019-06-30 $2.09B $0.45B 4.68
2019-03-31 $2.03B $0.44B 4.57
2018-12-31 $2.02B $0.45B 4.49
2018-09-30 $2.03B $0.45B 4.49
2018-06-30 $1.99B $0.44B 4.50
2018-03-31 $1.98B $0.46B 4.33
2017-12-31 $1.98B $0.50B 3.93
2017-09-30 $1.89B $0.47B 4.06
2017-06-30 $1.83B $0.46B 4.01
2017-03-31 $1.73B $0.41B 4.25
2016-12-31 $1.85B $0.47B 3.91
2016-09-30 $1.85B $0.44B 4.18
2016-06-30 $1.81B $0.41B 4.40
2016-03-31 $1.78B $0.40B 4.43
2015-12-31 $1.78B $0.44B 4.03
2015-09-30 $1.79B $0.44B 4.12
2015-06-30 $1.74B $0.40B 4.31
2015-03-31 $1.70B $0.42B 4.08
2014-12-31 $1.72B $0.45B 3.84
2014-09-30 $1.76B $0.50B 3.50
2014-06-30 $1.77B $0.48B 3.68
2014-03-31 $1.77B $0.48B 3.67
2013-12-31 $1.76B $0.49B 3.61
2013-09-30 $1.68B $0.46B 3.62
2013-06-30 $1.90B $0.43B 4.41
2013-03-31 $1.87B $0.45B 4.18
2012-12-31 $1.94B $0.47B 4.10
2012-09-30 $1.85B $0.43B 4.26
2012-06-30 $1.81B $0.42B 4.34
2012-03-31 $1.82B $0.44B 4.09
2011-12-31 $1.80B $0.46B 3.92
2011-09-30 $1.88B $0.42B 4.52
2011-06-30 $1.89B $0.44B 4.27
2011-03-31 $1.80B $0.43B 4.20
2010-12-31 $1.98B $0.67B 2.96
2010-09-30 $1.65B $0.41B 4.02
2010-06-30 $1.56B $0.39B 3.99
2010-03-31 $1.54B $0.40B 3.88
2009-12-31 $1.56B $0.42B 3.72
2009-09-30 $1.50B $0.42B 3.62
2009-06-30 $1.40B $0.38B 3.64
2009-03-31 $1.05B $0.36B 2.95
2008-12-31 $1.09B $0.42B 2.62
2008-09-30 $1.08B $0.39B 2.81
2008-06-30 $1.12B $0.41B 2.74
2008-03-31 $1.05B $0.39B 2.71
2007-12-31 $1.03B $0.41B 2.48
2007-09-30 $1.22B $0.29B 4.26
2007-06-30 $1.17B $0.28B 4.14
2007-03-31 $1.13B $0.27B 4.15
2006-12-31 $1.13B $0.32B 3.54
2006-09-30 $1.09B $0.28B 3.88
2006-06-30 $1.06B $0.28B 3.77
2006-03-31 $0.99B $0.26B 3.83
2005-12-31 $1.01B $0.32B 3.16
2005-09-30 $0.95B $0.30B 3.18
2005-06-30 $0.92B $0.29B 3.15
2005-03-31 $0.92B $0.30B 3.09
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $21.730B $2.546B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76